Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment? (Q36026873)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment?	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

Europe PubMed Central

Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment? (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

renal cell carcinoma

1 reference

based on heuristic

inferred from title

metastatic renal cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Jan Roigas

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Gero Massenkeil

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

World Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

213-220

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

https://scigraph.springernature.com/pub.10.1007/s00345-004-0480-2

0 references

Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 13-cis-retinoic acid on chemoimmunotherapy of metastatic renal cell carcinoma--results of a retrospective analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2003.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery from radiation injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: coordination of dendritic and CD8+ cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transpla

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for advanced renal cell cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15685446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00345-004-0480-2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36026873&oldid=1531317203"